the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.�.

the obvious reason: their big-spending pharmaceutical advertisers would drop them like hot potatoes. https://drbryanpwalsh.com/Cossaboom-grandpa-of-Hofer-from-Seamill?Bonaccida=229

may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful. october 2017  (17).